Ovarian Cancer (Clinical Trials)
Ovarian Cancer Prevention Trial Uses Vitamin A-Related Medicine
Published in Women's Health Weekly, January 15th, 2000
Women who have decided to have their ovaries removed may be eligible to take part in this clinical trial of cancer chemoprevention - the use of natural or man-made agents to prevent cancer.
The study uses a medicine, fenretinide, related to vitamin A. Past clinical studies have tested this drug as preventive medicine for cancers of the head and neck and breast cancer.
The goals of the new study are to determine whether fenretinide can stop the development of ovarian cancer, to identify...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Smoking
Research Helps Explain Why Women Have Harder Time Quitting Smoking - Birth Defects
Folic Acid During Pregnancy Prevents Neural-Tube Defects - Breast Cancer (Gene Therapy)
Cytokine Producing Cancer Cells Lose Tumorigenicity - Breast Cancer (Prognostics)
Mutation Doesn't Predict Breast Cancer Death - Breast Cancer (Risk Factors)
Scientists Report Marker of Increased Cancer Risk in Women with Benign Breast Disease - Breast Cancer (Screening)
Mammograms for Older Women Are of Questionable Value, Computer Model Suggests - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
